U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 139 results

Status:
US Approved Rx (2021)
First approved in 2011

Class (Stereo):
CHEMICAL (ACHIRAL)

Targets:


Deferiprone (trade name Ferriprox) is an iron chelator indicated for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate. Deferiprone is an orally bioavailable bidentate...
Status:
US Approved Rx (2021)
First approved in 2005

Class (Stereo):
CHEMICAL (ACHIRAL)

Targets:


Deferasirox (marketed as Exjade, Desirox, Deferasirox) is an iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. ...
Status:
US Approved Rx (2004)
First approved in 1995

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Dexrazoxane is a cardioprotective drug used in patients with breast cancer to reduce cardiomyopathy associated with doxorubicin administration. Dexrazoxane is believed to act by two mechanisms: it inhibits DNA topoisomerase II and acts as a chelator ...
Status:
US Approved Rx (1990)
First approved in 1990

Class (Stereo):
CHEMICAL (ABSOLUTE)

Targets:


Gluconolactone, a lactone of D-glucuronic acid, is a food additive with the E number E575. Gluconolactone is commonly found in honey, fruit juices, wine. In medcine, gluconolactone is used as a component of irrigation solution Renacidin for dissoluti...
Status:
US Approved Rx (2021)
First approved in 1988

Class (Stereo):
CHEMICAL (RACEMIC)



Tiopronin is a prescription thiol drug used primarily in the treatment of severe homozygous cystinuria. Patients with cystinuria excrete high levels of cystine in their urine and are at risk for kidney stone formation. Tiopronin is used as a second-l...
Status:
US Approved Rx (2018)
First approved in 1985

Class (Stereo):
CHEMICAL (ACHIRAL)

Targets:


Trientine, also known as triethylenetatramine or abbreviation TETA, is a highly selective divalent Cu(II) chelator and orphan drug that reverses copper overload in tissues. It was approved as second-line pharmacotherapy for Wilson's disease. Wilson's...
Status:
US Approved Rx (1991)
First approved in 1982

Class (Stereo):
CHEMICAL (MIXED)

Targets:


Succimer is an analogue of dimercaprol, and has replaced dimercaprol as one of the main antidotes used in the management of poisoning by lead and other heavy metals. The advantages of succimer are that it is effective by oral administration because i...
Status:
US Approved Rx (2010)
First approved in 1982

Class (Stereo):
CHEMICAL (ACHIRAL)



Ciclopirox is an antifungal medication indicated for the treatment of seborrheic dermatitis (Loprox trade name) and onychomycosis of fingernails and toenails due to Trichophyton rubrum (Penlac trade name). The drug exerts its action by chelating Fe3+...
Status:
US Approved Rx (2020)
First approved in 1970

Class (Stereo):
CHEMICAL (ABSOLUTE)

Targets:


Penicillamine, sold under the trade names of Cuprimine among others, is a medication primarily used for treatment of Wilson's disease, cystinuria and active rheumatoid arthritis. Penicillamine is a chelating agent recommended for the removal of exces...
Status:
US Approved Rx (2017)
First approved in 1968

Class (Stereo):
CHEMICAL (ACHIRAL)

Targets:


Deferoxamine (brand name Desferal) an iron chelator, is a drug for the treatment of acute iron intoxication and of chronic iron overload due to transfusion-dependent anemias. Deferoxamine chelates iron by forming a stable complex that prevents the ir...